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A B S T R A C T
A study was carried out to assess the efﬁcacy and the economic proﬁt of prophylactic
treatment against Isopsora suis with toltrazuril or with a sulfamethazine/trimethoprim
combination in piglets from an intensive pig farm. Thirty-one litters were included in
study. Eight litters were treated once with toltrazuril (20 mg/kg b.w.) at 3 days of age
(Toltra group); 8 litters were treated with the sulphonamide combination (sodium
sulfamethazine 35 mg and trimethoprim 7 mg/kg b.w.) for 3 consecutive days starting at 3
days of age (Sulfa group), and 15 litters were untreated (control group). Counts of oocyst
per gram on pooled feces sampled from each litter were carried out on Days 7, 14, 21 and
28 and diarrhea was registered daily from pooled samples. Piglets were weighed on Days
1, 7 and 28 and mean weight gain (WG) and daily weight gain (DWG) were evaluated. The
economic proﬁt of treatment was evaluated comparing the WG of piglets of each
treatment group from the day of birth to Day 28. On Days 14, 21 and 28, toltrazuril showed
a better efﬁcacy in controlling fecal oocyst output, diarrhea and weight gain compared
with sulphamidic treatment (P < 0.001). The budgeting analysis showed a return of
economic beneﬁt of s 0.915 per toltrazuril-treated piglets and an additional cost of s
1.155 per sulphonamide-treated piglets.
 2009 Elsevier B.V. All rights reserved.
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Isospora suis infection of suckling piglets is a condition
reported worldwide (Chae et al., 1998; Meyer et al., 1999;
Mundt et al., 2005). Recent investigations have shown that I.
suis is themost frequent parasite found in piglets aged 7–14
days and that the presence of the parasite is associatedwith
diarrhea in over 50% of naturally infected animals (Meyer* Corresponding author at: Dipartimento di Biologia Animale, Sezione
di Parassitologia e Malattie Parassitarie, Universita` degli Studi di Sassari,
Via Vienna 2, 07100 Sassari, Italy. Tel.: +39 079229465;
fax: +39 079229464.
E-mail address: scala@uniss.it (A. Scala).
0304-4017/$ – see front matter  2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.vetpar.2009.04.028et al., 1999; Sanna et al., 2002; Gualdi et al., 2003a). The
infection has an important negative impact on the swine
industry. Mortality is usually low, but high morbidity leads
to negative effects on the economic performance of farms
(Lindsay et al., 1992; Torres, 2004; Maes et al., 2007). In
addition, isosporosis seems to predispose the piglet to other
secondary infectious agents such as E. coli, Clostridium sp.
and rotavirus,which could considerably increasemorbidity,
mortality and management costs (Chae et al., 1998).
The economic loss from isosporosis is mainly due to the
growth retardationwhich can reach 20% in terms ofweight
loss and decreased daily weight gain, and which can be
extended into the post-weaning phase (Del Castillo et al.,
1996; Gherpelli and Barbieri, 1997). Presently, metaphy-
laxis against isosporosis with toltrazuril is recommended,
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toltrazuril is an anticoccidial triazin derivative that
signiﬁcantly reduces the shedding of oocysts and diarrheic
symptoms in infected piglets (Gualdi et al., 2003b; Busse,
2004; Mundt et al., 2007). The aim of this study was to
assess the efﬁcacy of toltrazuril and of a sulfamethazine/
trimethoprim combination given to suckling piglets 3 days
after birth and if there is an actual economic beneﬁt in such
a metaphylactic treatment in piglets from intensive
breeding farms.
2. Materials and methods
The study was carried out throughout 2006 on an
intensive swine farm located in Sardinia (approximately
1200 sows), where preliminary analyses showed the
presence of I. suis oocysts in the feces of suckling piglets.
Thirty-one litters of 11–13 piglets were monitored
starting from birth. The litters were bred in delivery
cages with grid ﬂoors. The litters were randomly divided
into 3 groups: Toltra group, consisting of 8 litters (98
piglets) treated at 3 days of age with an oral suspension
of toltrazuril at the dosage of 20 mg/kg b.w. (Baycox1
5%, Bayer, 0.4 ml/kg b.w. oral suspension); Sulpha group,
consisting of 8 litters (96 piglets) injected intra-muscle
at 3, 4 and 5 days of age with 2 ml/animal of a
combination of 25 g sodium sulfamethazine and 5 g
trimethoprim suspended in 100 ml of water for injec-
tions (corresponding to 250 mg/kg b.w. and 50 mg/kg
b.w.). Control group, consisting of 15 litters (191 piglets)
was left untreated throughout the study. Fecal samples
were collected on Days 7, 14, 21 and 28 after birth in
single pools for each litter containing at least 4 different
individual stools. Fecal examinations were carried out as
suggested by Mundt et al. (2006) and the number of
oocysts per gram (opg) was assessed in 2 McMaster
chambers (sensitivity 15 opg). Fecal consistency (normal
or diarrhea) was registered daily within pools collected
from each litter of Toltra group and Sulpha group and
from 8 litters of control group, randomly chosen at the
start of the study. Each animal was weighed on the day
of birth (Day 1) and then on Days 7 and 28 to assess the
individual weight (kg, BW) and the daily weight gain (kg,
DWG). The mean BW (SE), and the mean WG from Day 1
to Day 28 were calculated. The economic proﬁt of bothFig. 1. Prevalence of diarrhea in the difftreatments was evaluated comparing the mean WG of
piglets of each treatment group from the day of birth (Day
1) to Day 28. The treatment cost of Toltra was s 0.20/piglet
and of s 0.36/piglet of Sulpha. The time needed for treating
1 piglet was estimated at 15 s (about 5 min/litter) with a
labor cost of s 18/h.
The effect of treatments on opg output was evaluated
throughout generalized linear model (GLM) taking into
account the difference between groups and between
sampling times. In order to consider the aggregated
distribution of opg, the GLM was ﬁtted with a log link
function and negative binomial error structure. For each
treatment, opg count geometric mean (GM) and range
were calculated for each sampling time. The effect of
treatments on body weight was analyzed by ANOVA. All
statistical analyses were performed using Genstat 6th
edition and the cut off for statistical signiﬁcance was ﬁxed
at a probability P < 0.05.
3. Results and discussion
No difference was found with regard to mortality
between litters (P > 0.05). Both Toltra- and Sulpha-
treatment were well tolerated by piglets. On Day 7 after
treatment, I. suis oocysts were found in 2 of 8 fecal pools of
Toltra group (opgGM1.36, range 0–30), in 1 of 8 fecal pools
of Sulpha group (opg GM 0.67, range 0–60) and in 6 of 15
fecal pools of control group (opg GM 3.99, range 0–145).
On Day 14, oocysts were found in 1 of 8 fecal pools of Toltra
group (opg GM 0.45, range 0–15), in 6 of 8 fecal pools of
Sulpha group (opg GM 25.31, range 0–240) and in 14 of 15
fecal pools of control group (opg GM 543.33, range 0–
13,400). On Day 21, no oocyst was found in any fecal pool
from Toltra group, while 5 pools of Sulpha group (opg GM
10.36, range 0–390) and 12 pools of control group (opg GM
63.43, range 0–4285) were positive. On Day 28, 5 fecal
pools of Toltra group (opg GM 11.19, range 0–165), 7 of
Sulpha group (opg GM72.25, range 0–845) and 9 of control
group (opg GM 9.59, 0–150) were positive. The differences
between treatmentswere signiﬁcant onDays 14, 21 and 28
(P < 0.001).
Diarrhea was found in 4, 3 and 7 of 64 fecal pools of
Toltra group (respectively 6.3%, 4.7% and 10.9%) collected
daily fromDay 5 to Day 12, fromDay 13 to Day 20 and from
Day 21 to Day 28, respectively. At the same time intervals,erent treatment groups of piglets.
Table 2
Economic proﬁt based on mean weight gain following toltrazurin and
sulfamethazine/trimethoprim treatment of piglets.
Group
Toltra
Group
Sulfa
Control
Mean weight gain in kg/piglets
Days 1–28
5.457 4.576 4.858
Piglet value (s/kg) 2.00 2.00 2.00
Total piglet value in Euro based
on mean weight gain Days 1–28
10.91 9.15 9.72
Cost treatment per piglet: medicinal (s) 0.20 0.36 0
Cost treatment per piglet: labor (s) 0.075 0.225 0
Returns/piglet (s) 10.635 8.565 9.72
Difference in returns/piglet in
comparison with controls (s)
+0.915 1.155 –
Percent difference in cost/proﬁt
ratio/piglet between animal of
treated and control group
+8.60% 11.9% –
Mortality rate was not included because this parameter was not
statistically modiﬁed by anticoccidial treatments (P > 0.05).
Table 1
Mean body weight and daily body gain (standard error) of treated piglets
and untreated piglets.
Day 1 Day 7 Day 28
Group Toltra
A.m. b.w./piglet (kg) 1.599  0.072 2.101  0.105 7.056  0.172a
Daily body gain (kg) 0.101  0.013 0.225  0.0081
Group Sulfa
A.m. b.w./piglet (kg) 1.409  0.111 1.956  0.191 5.985  0.412b
Daily body gain (kg) 0.170  0.052 0.198  0.2132
Control group
A.m. b.w./piglet (kg) 1.528  0.057 2.270  0.059 6.386  0.167b
Daily body gain (kg) 0.147  0.009 0.188  0.0072
A.m.: arithmetical mean; within column, ﬁgures with different super-
scripts are signiﬁcant to at least 5% level of probability.
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group (respectively 4.7%, 32.8% and 48.4%) and 8, 44 and 18
in the control group respectively 12.5%, 68.8% and 28.1%)
(Fig. 1). I. suis opg counts and diarrhoea increased
signiﬁcantly from the Day 7 to Day 28 in Sulpha groups
(P < 0.001) while the differences were not signiﬁcant in
Toltra group. In the control group, the highest opg counts
were found on Day 14 andmost of diarrheic faecal samples
were found between Day 16 and Day 18 (Fig. 1). It seems to
conﬁrm that piglets both acquire immunity and developed
age resistance on the course of natural infections that were
able to decrease oocyst output and control clinical signs of
infection, as previously observed (Stuart et al., 1982;
Koudela and Kucˇerova´, 1999; Worliczek et al., 2007).
On Day 1 the BW and was 1.599 kg, 1.409 kg and 1.528
in Toltra group, Sulpha group and control group, respec-
tively (P > 0.05). On Day 7, the mean BW and DWG of
piglets in Toltra group were 2.101 kg and 0.102 kg,
respectively (Table 1). In Sulpha group, the mean BW
and DWG were 1.956 kg and 0.170 kg, respectively, and
2.270 kg and 0.147 kg in piglets from control group. On
Day 28, both the mean BW (7.056 kg) and the DWG
(0.225 kg) of piglets in Toltra group were signiﬁcantly
higher than in the other groups (Sulpha group, mean BW
5.985 kg; DWG 0.281 kg); control group, mean BW
6.386 kg, DWG 0.188 kg) (P < 0.05). The variations (SE)
in BW and DWG were very high in piglets of Sulpha group
on Day 28 (Table 1). The economic outcome of growth
performancewas expressed by additional net return/piglet
to medicinal and labor costs per piglet (Table 2). The
budgeting analysis showed a return of economic beneﬁt of
s 0.915 per Toltra-treated piglet and an additional cost of
s 1.155 per Sulpha-treated piglet.
In this study, the anticoccidial treatment was done at 3
days of age with toltrazuril and from Day 3 to Day 5 with
sulphonamides, during the prepatent period of infection
(Mundt et al., 2006). The choice to extend the observations
throughout the clinical disease period (6–9 days from
infection, Mundt et al., 2006) was done to evaluate how
long early treatment would be able to control oocyst
excretion by piglets and diarrhea. Although a variety of
factors inﬂuence isosporosis in piglets, not last the
immunity and the pressure of infection in the different
litters, it is of interest to note that from Day 10 to Day 28
the number of fecal pools with diarrheic feces in Toltragroup was signiﬁcantly lower both versus Sulpha group
and control group (P < 0.001). Furthermore, the infection
pressure in the different litters and the poor efﬁcacy of the
sulphonamides in restoring the normal morphology of
intestinal surface after experimental infection, as demon-
strated by Mundt et al. (2007), have apparently inﬂuenced
the growth performances of piglets and the high variations
in WG of piglets in Sulpha group.
Different approaches have been recommended to
decrease the survival of I. suis oocysts in the environment
and the risk of infection, mainly changing microclimatic
conditions in the farrowing pens (Longkiæer and Roep-
storff, 2008). However, in large pig farms it is difﬁcult to
increase the days between litters and, to some extent, to
maintain microclimatic conditions able to signiﬁcantly
decrease oocyst survival. Our results conﬁrms that
prophylactic treatment of piglets with toltrazuril is the
best option to control isosporosis in suckling piglets,
conﬁrming Mundt et al. (2007) ﬁndings in experimental
infections. The use of sulphonamide drugs is not
advisable. In this study on I. suis-infected piglets, no
efﬁcacy against the parasite andno economic beneﬁtwere
found.
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